CPF Texas’s Teva Pharmaceuticals TEVA Stock Holding History

CPF Texas’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-200	Closed	-$3K	–	254
2018 Q1	$3K	Hold	200	–	–	﹤0.01%	219
2017 Q4	$4K	Buy	+200	New	+$3.01K	﹤0.01%	250

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

CPF Texas's TEVA Position: Q2 2018 in Review

CPF Texas sold out of Teva Pharmaceuticals (TEVA) in Q2 2018, closing a stake of 200 shares — an estimated $3K sold.

CPF Texas first reported a position in TEVA in Q4 2017 and held it in 2 quarters. The position peaked at $4K in Q4 2017. 540 funds tracked by Wall St. Rank hold TEVA as of Q2 2018.

CPF Texas reported no remaining Teva Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
CPF Texas sold 200 Teva Pharmaceuticals shares in Q2 2018, an estimated $3K.
CPF Texas first reported a position in Teva Pharmaceuticals in Q4 2017 and held it in 2 quarters.
CPF Texas's Teva Pharmaceuticals position peaked at $4K in Q4 2017.
540 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2018.

Based on CPF Texas's 13F filing for Q2 2018, filed 3 Aug 2018.